Trials / Completed
CompletedNCT02759224
A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
An Open-Label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics of BRI-1501 Tablet and Coadministration of Lafutidine and Irsogladine maleate as Individual Tablets in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BRI-1501 | |
| DRUG | Lafutidine | |
| DRUG | Irsogladine maleate |
Timeline
- Start date
- 2016-04-15
- Primary completion
- 2016-07-01
- Completion
- 2016-12-29
- First posted
- 2016-05-03
- Last updated
- 2017-02-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02759224. Inclusion in this directory is not an endorsement.